Visit our new Alternative Investment section.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbbVie Share Price (ABBV.US)

Share Price Information for AbbVie (ABBV.US)

Share Price is delayed by 15 minutes
Get Live Data
210.00    -0.77 (-0.37%)
Bid:
209.24
Ask:
210.00
Spread: 0.76 (0.363%)
Market Cap: $367.57b
ABBV.US Live PriceLast checked at - CBOE

Intraday AbbVie Share Chart

  • This share is an international stock.
AbbVie Share Price
Price 210.00 Open 213.10
Bid 209.24 High 214.88
Ask 210.00 Low 209.10
Change -0.77 (-0.37%) Close 0.00
Volume 207,650
Currency USD
Issue Country US
Shares in Issue 1.77b
Market Cap $367.57b
PE Ratio 0.00
EPS 2.37
Year High 244.80
Year High Date 01-Oct-2025
Year Low 180.34
Year Low Date 22-May-2025
Dividend 0.00
Yield 0.00%
# Trades 6,248
Vol. Sold 111,254
Sold Value $8.06m
Vol. Bought 96,396
Bought Value $7.92m
Market Size 0
What if I invested $1,000 in AbbVie?
$ 1,004.83 (+0.48%)
1 month ago
$ 907.13 (-9.29%)
3 months ago
$ 903.77 (-9.62%)
6 months ago
$ 1,145.91 (+14.59%)
1 year ago
Add ABBV.US to WatchlistAdd ABBV.US to Watchlist

Compare Broker Offers

Selected partners may offer promotions for new customers. We may earn a referral fee if you open an account

Great for:
Spread Betting and CFDs
View Offer
Capital at risk
Great for:
0% commission
View Offer
Other fees apply.
Capital at risk.
Great for:
Larger Investment Pots
View Offer
Capital at risk
Great for:
Low Fees
View Offer
Capital at risk
Abbvie

Abbvie is listed on the CBOE trading with ticker code ABBV.US. It has a market capitalisation of $367.57b, with approximately 1.77b shares in issue. Over the last year, AbbVie share price has been traded in a range of 64.46, hitting a high of 244.80, and a low of 180.34.

AbbVie Inc. is a global biopharmaceutical company headquartered in North Chicago, Illinois. Established in 2013 as a spin-off from Abbott Laboratories, AbbVie focuses on discovering, developing, and commercialising advanced therapies. The company specialises in areas such as immunology, oncology, virology, and neuroscience. Notable products include Humira, Imbruvica, and Venclexta. Committed to innovation and patient care, AbbVie invests heavily in research and development to address complex and serious health conditions. With a strong emphasis on improving patient outcomes and quality of life, AbbVie is a recognised leader in the global biopharmaceutical industry.

Recent Share Trades for AbbVie (ABBV.US)

Date Time Trade Prc Volume Buy/Sell Bid Ask Value  
15-May-2617:38:31210.001Buy*209.24210.00210.00O Ordinary
15-May-2617:37:55210.001Sell*210.00210.39210.00O Ordinary
15-May-2616:59:00209.99103Buy*209.24211.6021.63kO Ordinary
15-May-2616:42:15210.0030Sell*209.24211.606,300O Ordinary
15-May-2616:41:10210.012Sell*210.00211.60420.02O Ordinary
15-May-2616:39:51210.0311Sell*210.00211.132,310O Ordinary
15-May-2616:28:45210.4911Buy*209.24210.492,315O Ordinary
15-May-2616:27:20210.2515Buy*209.74210.253,154O Ordinary
15-May-2616:20:13209.2220Sell*209.24211.134,184O Ordinary
15-May-2616:20:13209.951Sell*209.24211.13209.95O Ordinary
  • There are no chat posts for AbbVie